ACXP – acurx pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Acurx Pharmaceuticals files for secondary offering [Seeking Alpha]
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Acurx Pharmaceuticals announces $2.5 million registered direct offering [Seeking Alpha]
Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Form EFFECT Acurx Pharmaceuticals,
Form 4 Acurx Pharmaceuticals, For: Feb 05 Filed by: Shawah Robert G.
Form 4 Acurx Pharmaceuticals, For: Feb 05 Filed by: LUCI DAVID P
Form 4 Acurx Pharmaceuticals, For: Feb 05 Filed by: DELUCCIA ROBERT J
Form S-1 Acurx Pharmaceuticals,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.